The immunity provisions of the 1986 Vaccine Act gave a blank check to US pharmaceutical companies to promote the most shoddily tested vaccines without consequences or cost. Pharma responded with a gold rush to add new lucrative vaccines to the schedule, and by 1991, mercury exposures to US children from the vaccine preservative thimerosal had more than doubled.29